Outcomes of Coronary Artery Bypass Grafting in Israeli Jews and Arabs

Completed

• Conditions: CABG; Ethnic Group

• Registration Number: NCT06766123
• Lead Sponsor: Technion, Israel Institute of Technology

Brief Summary

Retrospective study of adult patients with multivessel disease undergoing isolated CABG in three centers between January 1st, 2009, and December 31st, 2023. The primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE). Patients were grouped according to their ethnic origin, Arabs and Jews.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-01-01
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Study First Submitted: 2024-12-27
• Status Verified: 2025-01
• Study First Submitted QC: 2025-01-03
• Last Update Submitted: 2025-01-03
• Study First Posted: 2025-01-09
• Last Update Posted: 2025-01-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 7067

Inclusion Criteria

• isolated CABG

Exclusion Criteria

• members of different HMO

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
MACCE	through study completion, a median of 78 months

Secondary Outcome Measures

Name	Time	Method
Mortality	through study completion, a median of 78 months
MI	through study completion, a median of 78 months
CVA	through study completion, a median of 78 months
repeat revascularization	through study completion, a median of 78 months
utilization of multi-arterial grafting	through study completion, a median of 78 months